Assignee
SLAYBACK PHARMA LLC
US·42 granted patents·27 pending applications·71 citations·filing 2018–2025
Top patents by PatentIndex Score
69 records- 0197US10874671B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Dec 29, 2020·17 cites·23 claims
- 0296US11679105B1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Jun 20, 2023·11 cites·13 claims
- 0396US11590122B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Granted Feb 28, 2023·14 cites·12 claims
- 0493US12138255B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·2 cites·6 claims
- 0593US11707450B1Stable pharmaceutical compositions of bendamustineSLAYBACK PHARMA LLC·Filed 2022·Granted Jul 25, 2023·5 cites·10 claims
- 0693US11484518B1Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Nov 1, 2022·2 cites·17 claims
- 0792US11878025B2Pharmaceutical compositions of mifepristoneSLAYBACK PHARMA LLC·Filed 2022·Granted Jan 23, 2024·4 cites·29 claims
- 0892US11793809B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Oct 24, 2023·2 cites·9 claims
- 0990US12233049B2Stable pharmaceutical compositions of clonidineSLAYBACK PHARMA LLC·Filed 2022·Granted Feb 25, 2025·4 cites·23 claims
- 1090US12213972B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Granted Feb 4, 2025·2 cites·18 claims
- 1189US12440474B2Stable pharmaceutical compositions of clonidineSLAYBACK PHARMA LLC·Filed 2025·Granted Oct 14, 2025·1 cites·19 claims
- 1289US12263176B2Pharmaceutical liquid compositions of meloxicamSLAYBACK PHARMA LLC·Filed 2023·Granted Apr 1, 2025·1 cites·14 claims
- 1389US11872305B2Stable pharmaceutical compositions of succinylcholine chlorideSLAYBACK PHARMA LLC·Filed 2022·Granted Jan 16, 2024·2 cites·13 claims
- 1488US12133912B2Stable pharmaceutical compositions of succinylcholine chlorideSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 5, 2024·1 cites·1 claims
- 1587US12128089B2Stable liquid compositions of glucagonSLAYBACK PHARMA LLC·Filed 2023·Granted Oct 29, 2024·1 cites·20 claims
- 1686US12151020B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2024·Granted Nov 26, 2024·0 cites·14 claims
- 1785US10702520B1Pharmaceutical compositions of posaconazoleSLAYBACK PHARMA LLC·Filed 2019·Granted Jul 7, 2020·2 cites·19 claims
- 1882US11938217B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2023·Granted Mar 26, 2024·0 cites·19 claims
- 1982US11696906B2Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Jul 11, 2023·0 cites·8 claims
- 2082US2025032508A1Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 2182US2026069570A1Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 2280US12208086B2Stable pharmaceutical compositions of bendamustineSLAYBACK PHARMA LLC·Filed 2023·Granted Jan 28, 2025·0 cites·7 claims
- 2380US12138271B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·0 cites·16 claims
- 2480US11564898B1Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Jan 31, 2023·0 cites·10 claims
- 2579US12370190B2Stable liquid compositions of netupitant and palonosetronSLAYBACK PHARMA LLC·Filed 2024·Granted Jul 29, 2025·0 cites·18 claims
- 2679US12133854B2Pharmaceutical compositions of mifepristoneSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 5, 2024·0 cites·12 claims
- 2779US11844784B2Stable pharmaceutical compositions of bendamustineSLAYBACK PHARMA LLC·Filed 2023·Granted Dec 19, 2023·0 cites·15 claims
- 2878US12343330B2Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2023·Granted Jul 1, 2025·0 cites·27 claims
- 2978US11957685B2Pharmaceutical compositions of tofacitinib for oral administrationSLAYBACK PHARMA LLC·Filed 2023·Granted Apr 16, 2024·0 cites·24 claims
- 3077US2025221978A1Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 3177US2024131018A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 3277US2025057855A1Pharmaceutical compositions of mifepristoneSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 3376US12491178B2Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Granted Dec 9, 2025·0 cites·18 claims
- 3476US2024207278A1Pharmaceutical compositions of tofacitinib for oral administrationSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 3575US11642355B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2022·Granted May 9, 2023·0 cites·15 claims
- 3674US12521383B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2025·Granted Jan 13, 2026·0 cites·17 claims
- 3774US12097197B2Stable liquid compositions of netupitant and palonosetronSLAYBACK PHARMA LLC·Filed 2022·Granted Sep 24, 2024·0 cites·24 claims
- 3874US2025082617A1Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 3974US2025049824A1Stable pharmaceutical compositions of cyclophosphamideSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 4072US2022387418A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 4172US2024180934A1Stable pharmaceutical compositions of cyclophosphamideSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 4272US2024122858A1Modified-release dosage forms of ruxolitinibSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 4371US12194028B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2023·Granted Jan 14, 2025·0 cites·16 claims
- 4471US11931370B2Stable pharmaceutical compositions of cyclophosphamideSLAYBACK PHARMA LLC·Filed 2022·Granted Mar 19, 2024·0 cites·4 claims
- 4571US11311554B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2019·Granted Apr 26, 2022·0 cites·6 claims
- 4671US11110054B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Sep 7, 2021·0 cites·10 claims
- 4771US10456354B1Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Oct 29, 2019·0 cites·21 claims
- 4871US2025235431A1Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 4971US2025032586A1Stable liquid compositions of glucagonSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 5070US2025248987A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SLAYBACK PHARMA LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →